Evaluation of Nutrients Intake for a Group of Jordanian Older Adults with Sarcopenia Syndrome in Amman: An Explorative and Pilot Study.
Journal
Journal of aging research
ISSN: 2090-2204
Titre abrégé: J Aging Res
Pays: United States
ID NLM: 101543460
Informations de publication
Date de publication:
2021
2021
Historique:
received:
30
11
2020
revised:
19
06
2021
accepted:
03
07
2021
entrez:
30
7
2021
pubmed:
31
7
2021
medline:
31
7
2021
Statut:
epublish
Résumé
Sarcopenia is an age-related syndrome that is characterized by a progressive loss of muscle mass, strength, and function. This study was performed in order to evaluate nutrients intake and physical activity level and to investigate the effect of sarcopenia syndrome on food intake for a group of Jordanian older adults with sarcopenia syndrome in Amman. The mean of the sarcopenic patients' age was 77.5 ± 6.9 years, and the mean of the weight was significantly lower in sarcopenic patients than the nonsarcopenic people. In this study, all macronutrients and micronutrients from dietary intake information were analyzed. Vitamin intake (water- and fat-soluble), as well as minerals (major and trace), amino acids, and essential fatty acids, was assessed. The mean intake of energy and carbohydrates, fat, and dietary fiber was lower than their recommendations, while the mean intake of protein was within the range of its recommendations in the sarcopenia group. The mean of the intake of omega 3 and omega 6 was below their recommendations. It could be concluded that sarcopenic older patients in Jordan have similar characteristics with patients studied worldwide with regard to age of patients, female to male ratio, and main symptoms. Sarcopenic older patients in Jordan generally have lower weight and BF% than nonsarcopenic adults and have inadequate dietary intake compared to their recommendations and compared to nonsarcopenic older adults. Therefore, the diet of sarcopenic patients needs modification and follow-up. The level of physical activity and daily living activities for sarcopenic older patients is lower than that of nonsarcopenic older adults.
Identifiants
pubmed: 34327020
doi: 10.1155/2021/6641967
pmc: PMC8310440
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6641967Informations de copyright
Copyright © 2021 Sarah Ziad Al-Majali et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Am Med Dir Assoc. 2016 May 1;17(5):393-401
pubmed: 26825685
J Nutr Health Aging. 2006 Nov-Dec;10(6):466-85; discussion 485-7
pubmed: 17183419
Clin Nutr. 2017 Feb;36(1):267-274
pubmed: 26689868
J Am Geriatr Soc. 2004 Jan;52(1):80-5
pubmed: 14687319
J Cachexia Sarcopenia Muscle. 2014 Sep;5(3):229-36
pubmed: 24737112
J Am Med Dir Assoc. 2013 Dec;14(12):911-5
pubmed: 24094646
J Gerontol A Biol Sci Med Sci. 2006 Jun;61(6):589-93
pubmed: 16799141
J Frailty Aging. 2018;7(1):47-50
pubmed: 29412442
J Gerontol A Biol Sci Med Sci. 2001 Jun;56(6):M366-72
pubmed: 11382797
Fam Pract. 2012 Apr;29 Suppl 1:i44-i48
pubmed: 22399555
Aging Clin Exp Res. 2017 Feb;29(1):43-48
pubmed: 28155181
Sci Rep. 2017 Jun 9;7(1):3171
pubmed: 28600505
J Am Geriatr Soc. 2010 Nov;58(11):2129-34
pubmed: 21054294
Eurasian J Med. 2011 Aug;43(2):109-14
pubmed: 25610174
J Nutr Health Aging. 2008 Aug-Sep;12(7):433-50
pubmed: 18615225
J Nutr Health Aging. 2006 Nov-Dec;10(6):456-63; discussion 463-5
pubmed: 17183418
Aging Clin Exp Res. 2019 Jun;31(6):815-824
pubmed: 30955158
J Nutr Health Aging. 2020;24(23):339-345
pubmed: 32115617
Geriatr Gerontol Int. 2012 Jul;12(3):388-96
pubmed: 22530761
Adv Biol Med Phys. 1956;4:239-80
pubmed: 13354513
J Am Med Dir Assoc. 2018 Jan;19(1):6-11.e3
pubmed: 28711425
Clin Geriatr Med. 2011 Aug;27(3):355-63
pubmed: 21824552
Wien Med Wochenschr. 2011 Sep;161(17-18):409-15
pubmed: 21792524
J Nutr. 2016 Dec;146(12):2625S-2629S
pubmed: 27934654